Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$2.65M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$334K |
| 3 |
Akamai
AKAM
|
+$322K |
| 4 |
Kraft Heinz
KHC
|
+$131K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$102K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Western Union
WU
|
+$3.91M |
| 2 |
Microchip Technology
MCHP
|
+$1.47M |
| 3 |
Microsoft
MSFT
|
+$1.32M |
| 4 |
Walt Disney
DIS
|
+$1.2M |
| 5 |
Boeing
BA
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.97% |
| 2 | Consumer Staples | 20.47% |
| 3 | Technology | 16.44% |
| 4 | Communication Services | 15.05% |
| 5 | Materials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
AT&T
T
$173B
| $6.83M | 3.72% |
235,864
-27,909
| -11% | -$769K |
|
2
Warner Bros
WBD
$71.6B
| $6.82M | 3.72% |
595,547
-62,487
| -9% | -$583K |
|
|
3
Boeing
BA
$169B
| $6.62M | 3.61% |
31,577
-5,961
| -16% | -$1.13M |
|
4
Estee Lauder
EL
$36.9B
| $6.59M | 3.6% |
81,599
-13,675
| -14% | -$880K |
|
|
5
Microsoft
MSFT
$3.59T
| $6.51M | 3.55% |
13,095
-3,050
| -19% | -$1.32M |
|
6
Nike
NKE
$60.5B
| $6.45M | 3.52% |
90,843
-2,168
| -2% | -$130K |
|
7
CVS Health
CVS
$119B
| $6.41M | 3.5% |
92,997
-7,453
| -7% | -$489K |
|
8
ASML
ASML
$677B
| $6.18M | 3.37% |
7,716
-1,561
| -17% | -$1.12M |
|
9
AB InBev
BUD
$155B
| $5.99M | 3.27% |
87,093
-16,757
| -16% | -$1.13M |
|
10
GSK
GSK
$105B
| $5.86M | 3.2% |
152,599
-12,544
| -8% | -$479K |
|
11
Pfizer
PFE
$160B
| $5.69M | 3.1% |
234,628
-6,953
| -3% | -$162K |
|
12
DuPont de Nemours
DD
$18.7B
| $5.64M | 3.08% |
65,504
-1,211
| -2% | -$101K |
|
13
International Flavors & Fragrances
IFF
$21.5B
| $5.49M | 3% |
74,680
-6,093
| -8% | -$460K |
|
|
14
Kraft Heinz
KHC
$30.3B
| $5.42M | 2.96% |
209,731
+4,733
| +2% | +$131K |
|
15
Baxter International
BAX
$13.6B
| $5.4M | 2.95% |
178,429
-3,583
| -2% | -$109K |
|
16
CarMax
KMX
$8.82B
| $5.35M | 2.92% |
79,610
-4,491
| -5% | -$302K |
|
17
Biogen
BIIB
$32B
| $5.27M | 2.88% |
41,972
-2,053
| -5% | -$256K |
|
18
Zimmer Biomet
ZBH
$19.3B
| $5.07M | 2.77% |
55,598
-2,959
| -5% | -$286K |
|
19
Brown-Forman Class B
BF.B
$13.1B
| $4.73M | 2.58% |
175,788
-14,491
| -8% | -$465K |
|
20
T. Rowe Price
TROW
$23.8B
| $3.7M | 2.02% |
38,294
-2,627
| -6% | -$241K |
|
|
21
TSMC
TSM
$2.17T
| $3.65M | 1.99% |
16,099
+14,295
| +792% | +$2.65M |
|
|
22
Walt Disney
DIS
$186B
| $3.57M | 1.95% |
28,762
-11,548
| -29% | -$1.2M |
|
23
Comcast
CMCSA
$95.3B
| $3.54M | 1.93% |
99,263
-9,312
| -9% | -$322K |
|
|
24
Microchip Technology
MCHP
$41.3B
| $3.49M | 1.9% |
49,536
-26,817
| -35% | -$1.47M |
|
25
Nucor
NUE
$55.3B
| $3.48M | 1.9% |
26,829
-3,836
| -13% | -$448K |
|
Similar funds
Mark Hillman's Q2 2025 Portfolio in Review
As of Q2 2025, Mark Hillman held 52 positions worth $183M, down 9.8% from $203M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mark Hillman withdrew a net $21.4M in Q2 2025, closing 2 positions and reducing 36 holdings. Its most notable exit was Western Union, an estimated $3.91M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Mark Hillman opened a new position in Akamai worth $331K.
- Mark Hillman's largest Q2 2025 buy was Akamai: 4,149 shares worth $331K.
- Mark Hillman added most to TSMC in Q2 2025, an estimated $2.65M increase.
- Mark Hillman's biggest Q2 2025 reduction was Microchip Technology, cutting an estimated $1.47M.
- Mark Hillman fully exited Western Union in Q2 2025, selling an estimated $3.91M.
- Mark Hillman's ten largest holdings make up 35% of its $183M portfolio in Q2 2025.
- Mark Hillman opened 1 new position and closed 2 in Q2 2025.
- Mark Hillman's portfolio value fell 9.8% quarter-over-quarter to $183M.
Based on Hillman Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.